Bioassays 2026: Scientific Approaches and Regulatory Strategies
April 28 - 29, 2026
Bioassays: Scientific Approaches & Regulatory Strategies is a premier bioassay symposium that presents a truly unique opportunity for attendees to interact with key industry thought leaders and discuss topics such as current perspectives, strategies, and technologies used for bioassays. This Symposium promises to maintain the tradition of high-quality case studies and scientific discussion that enables an additional focus on the technical and regulatory details of each topic. The program includes speakers, panel discussions, posters, exhibitors, and networking opportunities.
Bioassays 2026 Program Partners
The scientific organizing committees gratefully acknowledge the following program partners for their generous support of Bioassays 2026.
Strategic Diamond Program Partners |
Strategic Platinum
Program Partners |
Strategic Gold Program Partner | Strategic Silver Program Partner |
Amgen, Inc. AstraZeneca Biogen Eli Lilly and Company | Gilead Sciences, Inc. Pfizer Inc. Sanofi | Bristol-Myers Squibb Company | Johnson & Johnson |
Bioassays 2026 Exhibitors
The scientific organizing committee gratefully acknowledges the following exhibitors for their generous support of Bioassays 2026.
Exhibitor Platinum Program Partner | Exhibitor Gold Program Partner | Exhibitors | Leading Media Partners | |
Catalent, Inc. | BioAgilytix Labs, LLC | acCELLerate GmbH Charles River Laboratories Custom Biologics Labcorp Promega Corporation Stegmann Systems Svar Life Science | BioProcess International International Pharmaceutical Quality |